SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001628280-24-015621
Filing Date
2024-04-10
Accepted
2024-04-10 16:08:00
Documents
18
Period of Report
2024-06-11

Document Format Files

Seq Description Document Type Size
1 PRE 14A proxy-2024.htm PRE 14A 723892
2 claypoolesignatureii.jpg GRAPHIC 10041
3 dateimage.jpg GRAPHIC 9724
4 image_15.jpg GRAPHIC 4975
5 inpersonimage.jpg GRAPHIC 9911
6 internetimage.jpg GRAPHIC 9002
7 meetingaddress1of2v2.jpg GRAPHIC 327474
8 meetingaddress2of2v2.jpg GRAPHIC 573377
9 mlimage.jpg GRAPHIC 8891
10 proxycard1of2v2.jpg GRAPHIC 191410
11 proxycard2of2v2.jpg GRAPHIC 270347
12 recorddateimage.jpg GRAPHIC 10498
13 robertclaypoole.jpg GRAPHIC 17137
14 telephoneimage.jpg GRAPHIC 8735
15 timeimage.jpg GRAPHIC 8738
16 tonydadamiosignature.jpg GRAPHIC 12512
17 universelogo.jpg GRAPHIC 8391
18 whereimage.jpg GRAPHIC 9891
  Complete submission text file 0001628280-24-015621.txt   2725614
Mailing Address 4721 EMPEROR BOULEVARD, SUITE 100 DURHAM NC 27703
Business Address 4721 EMPEROR BOULEVARD, SUITE 100 DURHAM NC 27703 (919) 474-6700
Bioventus Inc. (Filer) CIK: 0001665988 (see all company filings)

IRS No.: 810980861 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-37844 | Film No.: 24835840
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)